Literature DB >> 8903762

Periventricular leukomalacia, glial development and myelination.

S Takashima1, K Iida, K Deguchi.   

Abstract

In perinatal leukomalacia, the brain pathology exhibits several different distribution patterns, according to cerebrovascular and glial maturity or various causal factors. Periventricular leukomalacia occurs in the prenatal as well as the postnatal period, and is caused by, in addition to predisposing factors, cerebral hypoperfusion which is in turn caused by systemic hypotension or intracranial vascular constriction and circulatory disturbance. Oligodendroglial damage or diffuse astrogliosis associated with leukomalacia may lead to delayed or reduced myelination in the cerebral white matter.

Entities:  

Mesh:

Year:  1995        PMID: 8903762     DOI: 10.1016/0378-3782(95)01675-9

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  5 in total

Review 1.  Magnetic resonance imaging of preterm brain injury.

Authors:  S J Counsell; M A Rutherford; F M Cowan; A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-07       Impact factor: 5.747

Review 2.  Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina.

Authors:  Charanjit Kaur; Gurugirijha Rathnasamy; Eng-Ang Ling
Journal:  J Neuroimmune Pharmacol       Date:  2012-02-26       Impact factor: 4.147

Review 3.  Maternal infection and white matter toxicity.

Authors:  G Jean Harry; Cindy Lawler; Susan H Brunssen
Journal:  Neurotoxicology       Date:  2006-05-17       Impact factor: 4.294

4.  Effects of disrupting calcium homeostasis on neuronal maturation: early inhibition and later recovery.

Authors:  Sarah L Ringler; Jamie Aye; Erica Byrne; Megan Anderson; Christopher P Turner
Journal:  Cell Mol Neurobiol       Date:  2008-01-15       Impact factor: 5.046

5.  Frontal horn cysts in normal neonates.

Authors:  Chaw-Liang Chang; Nan-Chang Chiu; Che-Sheng Ho; Sung-Tse Li
Journal:  Brain Dev       Date:  2006-02-28       Impact factor: 1.961

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.